A simulation study of the effect of lung cancer screening in China, Japan, Singapore, and South Korea

被引:7
|
作者
Chen, Yufan [1 ]
Watson, Tina R. [1 ]
Criss, Steven D. [1 ]
Eckel, Andrew [1 ]
Palazzo, Lauren [1 ]
Sheehan, Deirdre F. [1 ,3 ]
Kong, Chung Yin [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
来源
PLOS ONE | 2019年 / 14卷 / 07期
基金
美国国家卫生研究院;
关键词
SMOKING PREVALENCE; UNITED-STATES; MORTALITY; TRENDS; CT; OUTCOMES; PROGRAM; MODELS; IMPACT; NLST;
D O I
10.1371/journal.pone.0220610
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
More than 50% of the world's lung cancer cases occur in Asia and more than 20% of cancer deaths in Asia are attributable to lung cancer. The U. S. National Lung Screening Trial has shown that lung cancer screening with computed tomography ( CT) can reduce lung cancer deaths. Using the Lung Cancer Policy Model-Asia ( LCPM-Asia), we estimated the potential mortality reduction achievable through the implementation of CT-based lung cancer screening in China, Japan, Singapore, and South Korea. The LCPM-Asia was calibrated to the smoking prevalence of each of the aforementioned countries based on published national surveys and to lung cancer mortality rates from the World Health Organization. The calibrated LCPM-Asia was then used to simulate lung cancer deaths under screening and no-screening scenarios for the four countries. Using screening eligibility criteria recommended by the U. S. Centers for Medicare & Medicaid Services ( CMS), which are based on age and smoking history, we estimated the lung cancer mortality reduction from screening through year 2040. By 2040, lung cancer screening would result in 91,362 life-years gained and 4.74% mortality reduction in South Korea; 290,325 life-years gained and 4.33% mortality reduction in Japan; 3,014,215 life-years gained and 4.22% mortality reduction in China; and 8,118 life-years gained and 3.76% mortality reduction in Singapore. As for mortality reduction by smoker type, current smokers would have the greatest mortality reduction in each country, ranging from 5.56% in Japan to 6.86% in Singapore. Among the four countries, lung cancer screening under CMS eligibility criteria was most effective in South Korea and least effective in Singapore. Singapore's low smoking prevalence and South Korea's aging population and higher smoking prevalence may partially explain the discrepancy in effectiveness. CT screening was shown to be promising as a means of reducing lung cancer mortality in the four countries.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Exchange rate volatility and bilateral exports of Malaysia to Singapore, China, Japan, the USA and Korea
    Wong, Hock Tsen
    [J]. EMPIRICAL ECONOMICS, 2017, 53 (02) : 459 - 492
  • [42] China Japan and South Korea Football Reserve Talent Cultivation System Evaluation and Optimization Study
    Zheng, Daiyi
    [J]. EKOLOJI, 2019, 28 (107): : 3315 - 3318
  • [43] Pneumonia in Patients with Lung Cancer of South Korea: A Nationwide Population Based Study
    Lee, H. W.
    Jung, J.
    Heo, J.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S616 - S616
  • [44] Effect of preoperative psychiatric morbidity on postoperative outcomes of lung cancer surgery: A nationwide cohort study in South Korea
    Song, In-Ae
    Park, Hye Yoon
    Oh, Tak Kyu
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2022, 161
  • [45] A comparative study of international branch campuses in Malaysia, Singapore, China, and South Korea: regulation, governance, and quality assurance
    Hou, Angela Yung-Chi
    Hill, Christopher
    Chen, Karen Hui Jung
    Tsai, Sandy
    [J]. ASIA PACIFIC EDUCATION REVIEW, 2018, 19 (04) : 543 - 555
  • [46] A cross-country core strategy comparison in China, Japan, Singapore and South Korea during the early COVID-19 pandemic
    Chen, Haiqian
    Shi, Leiyu
    Zhang, Yuyao
    Wang, Xiaohan
    Sun, Gang
    [J]. GLOBALIZATION AND HEALTH, 2021, 17 (01)
  • [47] A cross-country core strategy comparison in China, Japan, Singapore and South Korea during the early COVID-19 pandemic
    Haiqian Chen
    Leiyu Shi
    Yuyao Zhang
    Xiaohan Wang
    Gang Sun
    [J]. Globalization and Health, 17
  • [48] Healthy volunteer effect in a lung cancer screening study
    Vehmas, Tapio
    Oksa, Panu
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2015, 24 (05) : 454 - 454
  • [49] A comparative study of international branch campuses in Malaysia, Singapore, China, and South Korea: regulation, governance, and quality assurance
    Angela Yung-Chi Hou
    Christopher Hill
    Karen Hui Jung Chen
    Sandy Tsai
    [J]. Asia Pacific Education Review, 2018, 19 : 543 - 555
  • [50] Challenges and Opportunities With the Use of Hypofractionated Radiation Therapy in Cancer Care: Regional Perspectives From South Korea, Japan, Singapore, and Australia
    Akimoto, Tetsuo
    Aoyama, Hidefumi
    Chua, Melvin L. K.
    Jayamanne, Dasantha
    Mizowaki, Takashi
    Morris, Lucinda
    Onishi, Hiroshi
    Song, Si Yeol
    Zeidan, Youssef H.
    Sharma, Ricky A.
    [J]. ADVANCES IN RADIATION ONCOLOGY, 2023, 8 (06)